Latest Asx Listing News

Findi Limited has voluntarily suspended trading of its shares pending an announcement on its ongoing strategic review and financing discussions, delaying the FY26 audited financial statements beyond the June 30 deadline.

Hawk Resources Limited has had its HWKOB securities suspended from trading pending compliance with ASX Listing Rule 2.5, affecting only this class of securities.

Daly Resources has posted a $352,743 loss for FY2025 amid aggressive expansion of its exploration portfolio, including the acquisition of the Huckitta and North Batten projects. The company is gearing up for a $10 million IPO in 2026 to fund its base metals and fluorite exploration ambitions.

Ballymore Resources has secured $5.2 million through an oversubscribed capital raise, boosting its capacity to fast-track exploration across multiple Queensland projects.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

Alligator Energy has secured a crucial option to acquire a lease enabling expanded exploration at its Samphire Project while addressing ASX concerns over recent trading linked to a Mineral Resource Estimate update.

The NSW Supreme Court has approved Aeris Resources' takeover of Peel Mining, setting in motion key dates for shareholder entitlements and trading suspension.

BOA Resources Ltd has voluntarily suspended trading of its shares on the ASX pending a potential acquisition announcement, with the suspension expected to last up to five trading days.

NoviqTech Limited has clarified that its planned divestment of Non-Coralia assets was not foreseen during its Coralia acquisition and reflects a strategic pivot to biochar carbon removal, with leadership changes aligned to this refocus.

Nova Minerals Corp. (ASX: NVA) has had its trading suspension lifted as of 18 June 2026, following the implementation of shareholder and warrant holder schemes of arrangement.

INOVIQ Limited confirms no undisclosed price-sensitive information amid recent share price surge, attributing the move to external research spotlighting upcoming EXO-OC ovarian cancer test data.

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.